Skip to main content
Loading

Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays

19 Nov 2024
Translational Immunology
Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays
  • From checkpoint inhibitors towards therapeutic vaccines, does one size fits it all?
  • Fit for purpose in vitro assay development
  • Early characterization and immunogenicity testing of lead candidates
  • Non-human primate in vitro assays
Industry Expert
Christoph Schifflers, Scientist Immuno-oncology - IQVIA Laboratories – In Vitro Immunology